Michael Makanga

Summary

Publications

  1. ncbi Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
    Steven E Kern
    Department of Pharmaceutics, University of Utah, Salt Lake City, Utah, USA
    Malar J 10:210. 2011
  2. ncbi Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
    Bernhards Ogutu
    Walter Reed Project Centre for Clinical Research Kenya Medical Research Institute, Nairobi, Kenya
    Malar J 9:30. 2010
  3. ncbi The clinical efficacy of artemether/lumefantrine (Coartem)
    Michael Makanga
    European and Developing Countries Clinical Trials Partnership, Francie van Zijl Drive, Parow, PO Box 19070, Tygerberg 7505, Cape Town, South Africa
    Malar J 8:S5. 2009
  4. ncbi Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis
    Michael Makanga
    European and Developing Countries Clinical Trials Partnership, Cape Town, South Africa
    Am J Trop Med Hyg 85:793-804. 2011

Collaborators

Detail Information

Publications4

  1. ncbi Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
    Steven E Kern
    Department of Pharmaceutics, University of Utah, Salt Lake City, Utah, USA
    Malar J 10:210. 2011
    ..Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area...
  2. ncbi Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
    Bernhards Ogutu
    Walter Reed Project Centre for Clinical Research Kenya Medical Research Institute, Nairobi, Kenya
    Malar J 9:30. 2010
    ..The potential of this intervention was considered by key scientists in the field at an Advisory Board meeting held in Basel, in April 2009. This article summarizes the discussions that took place among the participants...
  3. ncbi The clinical efficacy of artemether/lumefantrine (Coartem)
    Michael Makanga
    European and Developing Countries Clinical Trials Partnership, Francie van Zijl Drive, Parow, PO Box 19070, Tygerberg 7505, Cape Town, South Africa
    Malar J 8:S5. 2009
    ....
  4. ncbi Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis
    Michael Makanga
    European and Developing Countries Clinical Trials Partnership, Cape Town, South Africa
    Am J Trop Med Hyg 85:793-804. 2011
    ..falciparum malaria. Artemether-lumefantrine showed high cure rates and rapid resolution of parasitemia, fever, and gametocytemia in adults and children, and showed an excellent safety and tolerability profile...